Antibiotic prescribing for patients with colds, upper respiratory tract infections, and bronchitis: A national study of hospital-based emergency departments

Annals of Emergency Medicine

Volumn 36, Issue 4, 2000, Pages 320-327

  Stone, Susan ^a   Gonzales, Ralph ^a   Maselli, Judith ^a   Lowenstein, Steven R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC RESISTANCE; ARTICLE; BRONCHITIS; COMMON COLD; COST CONTROL; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; SMOKING; UPPER RESPIRATORY TRACT INFECTION;

EID: 0033769922     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2000.109341     Document Type: Article

References (65)

1. Resistance to antimicrobial drugs: A worldwide calamity
2. The crisis in antibiotic resistance
3. Epidemiology of drug resistance: Implications for a post-antimicrobial era
4. Minimizing the impact of drug-resistant streptococcus pneumeniae (DRSP): A strategy from the DRSP working group
5. Infectious disease: A threat to global health and security
6. The challenges of emerging infectious diseases: Development and spread of multiply-resistant bacterial pathogens
7. Drug-resistant pneumococcal infections in the United States: A problem for clinicians, laboratories and public health
8. Preventing the emergence of antimicrobial resistance: A call for action by clinicians, public health officials and patients
9. The continued emergence of drug-resistant streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance system
10. Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group
11. Surveillance of antimicrobial resistance among respiratory tract pathogens in the United States, 1997 to 1998
12. Geographic variation in penicillin resistance in Streptococcus pneumoniae - Selected sites, United States, 1997
13. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae
14. Emergence of drug-resistant pneumococcal infections in the United States
15. Prevalance of antimicrobial resistance among respiratory tract isolates of streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
16. Interim guidelines for prevention and control of straphylococcal infection associated with reduced susceptibility to vancomycin
17. Multidrug resistance: A sign of the times
18. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women
19. Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms and clinical management
20. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Therapeutic realities and possibilities
21. Emergence of multidrug-resistant Salmonella enterica infections in the United States
22. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
23. Update: Staphylococcus aureus with reduced susceptibility to vancemycin - United States, 1997
24. The pneumococous at the gates
25. Antimicrobial drug resistance
26. Resistant pneumococoi: Protecting patients through judicious use of antibiotics
27. The spread of multiply resistant streptococcus pneumoniae at a day care center in Ohio
28. Risk factors for carriage of drug-resistant pneumococci among children in Memphis, Tennessee
29. Do antimicrobials increase the carriage rate of penicillin-resistant pneumococci in children? Cross-sectional prevalence study
30. Why do physicians prescribe antibiotics for children with upper respiratory tract infections?
31. Decreasing antibiotic use in ambulatory practice: Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults
32. Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis by ambulatory care physicians
33. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections
34. Careful antibiotic use to prevent resistance
35. Randomized placebo-controlled trials for acute bronchitis: A critical review of the literature
36. Treatment of acute bronchitis in adults without underlying disease
37. Quantitative systematic review of randomized controlled trials comparing antibiotic with placebo for acute cough in adults
38. Are antibiotics effective treatment for acute bronchitis? A meta-analysis
39. Antibiotics in acute bronchitis: A meta-analysis
40. Trends in antimicrobial drug prescribing among office-based physicians in the United States
41. Current management of acute bronchitis in ambulatory care: The use of antibiotics and bronchodilation
42. Antibiotics and upper respiratory infection: Do some folks think there is a cure for the common cold?
43. 'Equivalent sample size' and 'equivalent degrees of freedom': Refinements for inference using survey weights under superpopulation models
44. A study of the work force in emergency medicine
45. Antibiotics for colds in children: Who are the high prescribers?
46. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met?
47. Colour of respiratory discharge and antibiotic use
48. Patient knowledge of upper respiratory infections: Implications for antibiotic expectations and unnecessary utilization
49. The relationship between purulent manifestations and antibiotic treatment of upper respiratory tract infections
50. Knowledge and behavior related to antibiotic use for acute respiratory illness: Is our message clear?
51. The cost of antibiotics in treating upper respiratory tract infections in a Medicaid population
52. Antibiotics: Neither cost-effective nor 'cough' effective
53. Principles of educational outreach ('academic detailing') to improve clinical decision-making
54. An emergency department-based pneumococcal vaccination program could save money and lives
55. Demonstration of the feasibility of emergency department immunization against influenza and pneumococcus
56. Icelandic prescribers are showing the way to bring down the rates of antibiotic-resistant bacteria
57. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance
58. Reducing antibiotic use in ambulatory practice: Impact on patient-centered outcomes